David Tabatadze
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$5.1MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $5.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 20, 2021 | NIH | SBIR Phase I Highly Selective Pathogen Inactivators For Treatment of Convalescent Transfusion Plasma | $718K | ZATA PHARMACEUTICALS, INC. |
| Mar 15, 2020 | NIH | SBIR Phase II A CLOSED SYSTEM FOR PATHOGEN REDUCTION OF RED BLOOD CELLS FOR TRANSFUSION | $2.2M | ZATA PHARMACEUTICALS, INC. |
| Sep 1, 2018 | NIH | SBIR Phase I New-Generation of Fluorescently-Labeled Charge-Neutralized Oligonucleotides as Probes for the Detection and Quantification of MicroRNAs and Oligonucleotide-Based Therapeutics in Biological Samples | $402K | ZATA PHARMACEUTICALS, INC. |
| Jun 1, 2016 | NIH | SBIR Phase II SELF NEUTRALIZING OLIGONUCLEOTIDES WITH ENHANCED CELLULAR UPTAKE | $1.4M | ZATA PHARMACEUTICALS, INC. |
| Sep 1, 2015 | NIH | SBIR Phase I AZIRIDINYL GROUPS CONTAINING POLYAMINES AS ANTI-PATHOGEN DEVICE FOR BLOOD PRODUCTS INTENDED FOR TRANSFUSION | $403K | ZATA PHARMACEUTICALS, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#266
Awards as PI#417
Patents#273
Companies
- ZATA PHARMACEUTICALS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.